Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "Biochemistry" patented technology

Biochemistry, sometimes called biological chemistry, is the study of chemical processes within and relating to living organisms. Biochemical processes give rise to the complexity of life. A sub-discipline of both biology and chemistry, biochemistry can be divided in three fields; molecular genetics, protein science and metabolism. Over the last decades of the 20th century, biochemistry has through these three disciplines become successful at explaining living processes. Almost all areas of the life sciences are being uncovered and developed by biochemical methodology and research. Biochemistry focuses on understanding how biological molecules give rise to the processes that occur within living cells and between cells, which in turn relates greatly to the study and understanding of tissues, organs, and organism structure and function.

Supercritical extraction method of conic gymnadenia tuber element

The invention relates to a supercritical extraction method of a conic gymnadenia tuber element, and in particular relates to a method for extracting a natural active ingredient with an anti-aging effect, i.e. the conic gymnadenia tuber element, from a Tibetan medicine conic gymnadenia tuber. According to the invention, through creating a series of new extraction process conditions of pressure, temperature, entrainer and the like and the method, the traditional extraction contradiction of active ingredient purity and extraction rate are solved. Anti-aging medicines, health care products and human hand and face skin care products, which are manufactured through taking the conic gymnadenia tuber element as a basic formula, have the characteristics of nature, safety, transdermal absorption, no side effect and the like.
Owner:SHENZHEN RAPOS LLC

Engineered ketoreductase polypeptide and method for preparing montelukast midbody by means of same

InactiveCN106011092AOvercome poor responsivenessReduce the amount of enzymes usedOxidoreductasesFermentationBiochemistrySubstrate concentration
The invention discloses an engineered ketoreductase polypeptide and a method for preparing a montelukast midbody by means of the same. Compared with the prior art, the engineered ketoreductase polypeptide has the advantages that enzyme consumption is low, reaction time is short, substrate concentration is high, and the engineered ketoreductase polypeptide is more suitable for industrial application when used for preparation of the montelukast midbody.
Owner:ENZYMEWORKS

Valproic acid drug concentration detection kit and application thereof

The invention discloses a kit for detecting valproic acid drug concentration in dry blood spots. The kit comprises a kit body, a first container, a calibrator card and a quality control card, whereinthe calibrator card is a blood spot collection card fixed with a group of valproic acid dry blood spot samples as dry blood spot calibration points, and the number of the dry blood spot calibration points is at least six, the quality control material card is a blood spot collection card fixed with at least one group of valproic acid dry blood spot samples as dry blood spot quality control points,the number of each group of dry blood spot quality control points is at least three, the first container is filled with an internal standard extracting solution, and an internal standard adopts isotopic substituted valproic acid. The invention further discloses a detection method of the kit. The kit provided by the invention has advantages of simple preparation of reagents, less required amount ofsamples, convenience in storage and transportation, rapid pretreatment, short analysis period, lower cost and the like, and is suitable for popularization in clinical conventional detection.
Owner:WUXI APPTEC ZK SUZHOU BIOSCIENCE CO LTD

Method for purifying natural capsaicin

ActiveCN106431961ABest stirring speedOptimal mixing timeCarboxylic acid amide separation/purificationBiotechnologyCapsicum annuum
The invention relates to the field of pepper processing and specifically discloses a method for purifying natural capsaicin. The method comprises the following steps: decomposing the pepper into three parts, including embryo tissues, peels and pepper seeds; respectively smashing the three parts; adding a corresponding amount of cellulase into the smashed tissues; stirring and mixing at different rotating speeds and for different stirring durations; accelerating the damage to cells; accelerating the separation of capsaicin; extracting the capsaicin from the pepper tissues; dissolving the capsaicin in a solution; and then separating capsaicin crystals from the solution, thereby completing the whole capsaicin extracting and purifying processes. According to the scheme, the pepper is divided into three parts and the three parts in different capsaicin contents are respectively processed, so that the separation of the capsaicin as much as possible can be guaranteed.
Owner:GUIZHOU ZUNYI XINJIAYU FOOD CO LTD

Bronchoalveolar lavage fluid obtained for in-vitro lung and obtaining method of bronchoalveolar lavage fluid

ActiveCN114767977ADisease diagnosis is beneficialEnrich biological informationCannulasEnemata/irrigatorsLung alveolusBronchial epithelium
The invention relates to the technical field of bronchoalveolar lavage, and aims to provide in-vitro lung bronchoalveolar lavage fluid and an acquisition method thereof. The bronchoalveolar lavage fluid obtained for the in-vitro lung contains rich biological information, and the obtaining method is harmless to a patient and free of danger and meets ethical requirements.
Owner:GUANGZHOU INST OF RESPIRATORY HEALTH (GUANGZHOU INST OF RESPIRATORY DISEASES)

Preparation method and application of fluorescent reagent strip for quantitatively detecting concentration of ProAKAP4

PendingCN112630437ARealize quantitative detection of single servingReduce testing costsDisease diagnosisBiological testingReagent stripSemen
The invention discloses a preparation method and application of a fluorescent reagent strip for quantitatively detecting the concentration of ProAKAP4, and belongs to the field of in-vitro diagnostic reagents; a fluorescence immunochromatography technology is introduced into the detection of proAKAP4, and the prepared immunochromatography test strip for proAKAP4 adopts a double-antibody sandwich method; a proAKAP4 antigen in a sample pad is combined with a proAKAP4 antibody marked by fluorescent microspheres on a marking pad under the chromatographic action to form a compound, the compound moves to a detection line of a coating film under the chromatographic action, and the detection line of the coating film is coated with an antibody for identifying the other epitope of the proAKAP4 antigen to form a double-antibody sandwich compound; proAKAP4 with the concentration as low as 0.1 ng/mL in a seminal fluid sample can be detected, a detection result can be read through an immunofluorescence analyzer, professional operators are not needed, single-person quantitative detection of proAKAP4 is achieved, and the kit has the advantages of being convenient and rapid to use, easy to operate, high in sensitivity, easy to operate, low in detection cost and the like.
Owner:普迪特泰州生物科技有限公司

Polypeptide, preparation method of polypeptide, bispecific antibody and application of bispecific antibody

ActiveCN114085376AEasy to prepareEasy to manufactureHybrid immunoglobulinsAntibody ingredientsFc bindingIntravenous gammaglobulin
The invention relates to the technical field of biology, in particular to a polypeptide, a preparation method of the polypeptide, a bispecific antibody and application of the bispecific antibody. The polypeptide is an Fc binding polypeptide, and can be universally, simply and conveniently connected with a monoclonal antibody to prepare a bispecific / multispecific antibody. The polyvalent Fc binding polypeptide PGLU-Fc-III-4C or PASP-Fc-III-4C is prepared by bonding side carboxyl groups of polyglutamic acid (PGLU) or polyaspartic acid (PASP) with Fc-III-4C polypeptide which has general high affinity to an immune globulin (antibody) constant region (Fc), and the polyvalent Fc binding polypeptide can react with various monoclonal antibodies in different proportions in an aqueous solution to obtain a bispecific / multispecific antibody. The preparation method of the bispecific / multispecific antibody has the following advantages: the bispecific / multispecific antibody is prepared by direct incubation in a water environment, the reaction condition is mild, and the activity of the monoclonal antibody can be retained to the greatest extent; and the method is simple, efficient, controllable in monoclonal antibody proportion and high in universality, and has an industrialization prospect.
Owner:CHANGCHUN INST OF APPLIED CHEMISTRY - CHINESE ACAD OF SCI

Reduction of interferences in immunoassays

PendingUS20200400654A1Easy to detectReliable resultsBiological testingAssay labelsAnalyteChemical compound
The present invention relates to a method for determining an analyte in a sample, comprising a) contacting said sample with at least a first and a second detector compound; b) determining the amount of complexes comprising at least one detector compound; and, c) determining said analyte in a sample based on the result of step b), wherein said first detector compound comprises a first binding moiety and a first label, and said second detector compound comprises a second binding moiety and a second label, and wherein the first label and the second label are non-identical. The present invention further relates to a kit for detecting an analyte in a sample, comprising at least a first and a second detector compound for said analyte, wherein said first detector compound comprises a first binding moiety and a first label, and said second detector compound comprises a second binding moiety and a second label, and wherein the first label and the second label are non-identical; and to a device for determining an analyte in a sample, comprising at least a first and a second detector compound for said analyte, wherein said first detector compound comprises a first binding moiety and a first label, and said second detector compound comprises a second binding moiety and a second label, and wherein the first label and the second label are non-identical; and means for determining at least one signal obtained from said first label and said second label; and to the use of a composition comprising at least a first and a second detector compound for detecting an analyte, wherein said first detector compound comprises a first binding moiety and a first label, and said second detector compound comprises a second binding moiety and a second label, and wherein the first label and the second label are non-identical.
Owner:ROCHE DIAGNOSTICS OPERATIONS INC

Cucumber exosome-like vesicles containing cucurbitacin B and capable of being used as anti-cancer drugs

ActiveCN112472731AGuaranteed stabilityInhibitory activityOrganic active ingredientsAntineoplastic agentsCancer cellTumor therapy
The invention discloses cucumber exosome-like vesicles containing cucurbitacin B and capable of being used as anti-cancer drugs. Cucurbitacin B can be used for inhibiting proliferation of various cancer cells, but an extraction method of cucurbitacin B is complex and time-consuming. The method of separating the cucumber exosome-like vesicles to obtain cucurbitacin B has the advantages of easinessand quickness in operation and the like, and the lipid bilayer of the exosome-like vesicles is used as a natural protective film of cucurbitacin B, so that the stability of cucurbitacin B can be maintained for a long time. Moreover, through the principle of similarity and intermiscibility, the intake rate of cells to cucurbitacin B is also improved to a certain extent due to the existence of the lipid bilayer. When the cucumber exosome-like vesicles act on human alveolar basal epithelial cells (A549 cells) of adenocarcinoma, the maximum cell activity inhibition rate of the cucumber exosome-like vesicles is twice that of a cucurbitacin B standard substance, the dosage is lower, the toxicity to normal cells and the drug resistance to cancer cells can be reduced, and the cucumber exosome-likevesicles have good anti-cancer potential and industrialization prospect, and have an important significance in the clinical tumor treatment application.
Owner:FUJIAN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products